Questions, Feedback & Help
Send us an email and we'll get back to you ASAP. Or you can read our Frequently Asked Questions.

WormBase Tree Display for Gene: WBGene00004259

expand all nodes | collapse all nodes | view schema

Name Class

WBGene00004259EvidencePerson_evidenceWBPerson460
SMapS_parentSequenceD2085
IdentityVersion1
NameCGC_namepyr-1Person_evidenceWBPerson460
Sequence_nameD2085.1
Molecular_nameD2085.1
D2085.1.1
CE41886
Other_nameCELE_D2085.1Accession_evidenceNDBBX284602
Public_namepyr-1
DB_infoDatabase (13)
SpeciesCaenorhabditis elegans
HistoryVersion_change107 Apr 2004 11:29:34WBPerson1971EventImportedInitial conversion from geneace
StatusLive
Gene_infoBiotypeSO:0001217
Gene_classpyr
Allele (96)
StrainWBStrain00029944
WBStrain00029948
WBStrain00036893
RNASeq_FPKM (74)
GO_annotation (47)
Contained_in_operonCEOP2740
CEOP2376
Ortholog (34)
Structured_descriptionConcise_descriptionpyr-1 encodes the C. elegans protein CAD which is orthologous to the human gene Carbamyl phosphate synthetase I (CPS1); pyr-1 encodes a single protein with predicted carbamoyl phosphate synthetase, aspartate transcarbamoylase, and dihydroorotase activities (CAD), which is involved in pyrimidine biosynthesis; pyr-1 mutants can be rescued by the supply of exogenous pyrimidines; genetic interaction studies indicate that pyr-1 may function upstream of sqv-1, sqv-2, rib-1 and rib-2, genes involved in heparan sulphate proteoglycan biosynthesis, by providing pyrimidine for nucleotide sugars essential for the synthesis of heparan sulphate proteoglycan; pyr-1 is essential for viability and for proper morphogenesis of the pharynx, indicating that proteoglycan synthesis is essential for pharyngeal organogenesis.Paper_evidenceWBPaper00004637
WBPaper00031153
Curator_confirmedWBPerson324
WBPerson1823
WBPerson567
Date_last_updated28 Feb 2011 00:00:00
Automated_descriptionPredicted to enable aspartate carbamoyltransferase activity and dihydroorotase activity. Predicted to contribute to carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity. Involved in several processes, including pharyngeal gland morphogenesis; pharynx development; and pyrimidine nucleobase biosynthetic process. Predicted to be located in cytosol. Expressed in intestine. Used to study carbamoyl phosphate synthetase I deficiency disease and orotic aciduria. Human ortholog(s) of this gene implicated in developmental and epileptic encephalopathy 50. Is an ortholog of human CAD (carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase).Paper_evidenceWBPaper00065943
Curator_confirmedWBPerson324
WBPerson37462
Inferred_automaticallyThis description was generated automatically by a script based on data from the WS291 version of WormBase
Date_last_updated29 Nov 2023 00:00:00
Disease_infoExperimental_modelDOID:9280Homo sapiensPaper_evidenceWBPaper00035924
Accession_evidenceOMIM237300
Curator_confirmedWBPerson324
Date_last_updated03 Oct 2018 00:00:00
DOID:0050833Homo sapiensPaper_evidenceWBPaper00035924
Curator_confirmedWBPerson324
Date_last_updated26 Feb 2014 00:00:00
Potential_modelDOID:0080419Homo sapiensInferred_automaticallyInferred by orthology to human genes with DO annotation (HGNC:1424)
Disease_relevanceHuman Carbamoylphosphate synthetase (CPS1), a mitochondrial isozyme, acts in the urea cycle to generate carbomoyl phosphate, for the end-production of urea; CPS1 when mutated, causes hyperammonemia (Carbamoylphosphate synthetase I deficiency), an autosomal recessive metabolic disease, leading to the accumulation of toxic ammonia in the body leading to neurological problems; CPS1 is also associated with increased risk of pulmonary hypertension in newborns; C. elegans pyr-1/CPS1/CAD is required for morphogenesis of the pharynx, which requires both de novo synthesis of pyrimidines and synthesis of heparan sulfate proteoglycans (HSPG); pyr-1 functions in de novo pyrimidine synthesis and functions upstream of proteoglycan synthesizing enzymes by providing precursors of UDP-sugars essential for HSPG.Homo sapiensPaper_evidenceWBPaper00031153
WBPaper00035924
Accession_evidenceOMIM237300
615371
608307
Curator_confirmedWBPerson324
Date_last_updated21 Feb 2014 00:00:00
Models_disease_in_annotationWBDOannot00000274
Models_disease_assertedWBDOannot00000316
Molecular_infoCorresponding_CDSD2085.1
Corresponding_transcriptD2085.1.1
Other_sequence (72)
Associated_feature (12)
Experimental_infoRNAi_result (15)
Expr_patternExpr7805
Expr1013513
Expr1032102
Expr1147495
Expr2015206
Expr2033440
Drives_constructWBCnstr00012938
WBCnstr00035604
Construct_productWBCnstr00012938
WBCnstr00035604
Microarray_results (21)
Expression_cluster (226)
Interaction (254)
Map_infoMapIIPosition0.833913Error0.001725
PositivePositive_cloneD2085Inferred_automaticallyFrom CDS info
From sequence, transcript, pseudogene data
Mapping_dataPos_neg_data10785
10786
10787
10788
10789
Pseudo_map_position
ReferenceWBPaper00018955
WBPaper00031153
WBPaper00033751
WBPaper00035924
WBPaper00038491
WBPaper00049181
WBPaper00055090
WBPaper00057708
WBPaper00061547
WBPaper00065181
RemarkMap position created from combination of previous interpolated map position (based on known location of sequence) and allele information. Therefore this is not a genetic map position based on recombination frequencies or genetic experiments. This was done on advice of the CGC.CGC_data_submission
MethodGene